Skip to main content
Epigral Limited logo

Epigral Limited — Investor Relations & Filings

Ticker · EPIGRAL ISIN · INE071N01016 LEI · 3358008YTT28JYLL4516 BSE.NS Manufacturing
Open in API
Filings indexed 551 across all filing types
Latest filing 2024-04-22 Earnings Release
Country IN India
Listing BSE.NS EPIGRAL

About Epigral Limited

https://epigral.com/

Epigral Limited, formerly Meghmani Finechem Limited, operates an integrated chemical complex specializing in chlor-alkali and derivative products. The company’s core portfolio includes caustic soda, chlorine, and hydrogen, which serve as building blocks for its value-added downstream products. Key offerings include chloromethanes, hydrogen peroxide, and CPVC resin. Epigral is the first domestic producer of Epichlorohydrin (ECH), utilizing a bio-based manufacturing process. Its products are essential inputs for various applications in pharmaceuticals, textiles, water treatment, and plastics. The company focuses on expanding its specialty chemical portfolio through backward and forward integration, utilizing advanced technology to optimize production efficiency and meet the requirements of diverse global markets.

Recent filings

Filing Released Lang Actions
Press Release
Earnings Release Classification · 95% confidence The document is a press release announcing the audited financial results for the quarter and full year ended March 31, 2024 (Q4 & FY2024). It includes detailed financial highlights such as PAT, revenue, EBITDA, margins, operational highlights, and strategic updates including capex and dividend proposals. The document references Regulation 30 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, which pertains to disclosure of financial results. The content is typical of an Earnings Release (ER) as it provides key financial results and highlights for a specific quarter and fiscal year, rather than a full annual report or detailed management discussion. The length (6895 characters) and detailed financial data support classification as an Earnings Release rather than a brief announcement or a full Annual Report (10-K).
2024-04-22 English
Investor Presentation
Investor Presentation Classification · 100% confidence The document is titled as an "Investors Presentation for Audited Financial Results – Q4 & FY2024" and is addressed to stock exchanges under SEBI regulations. It contains detailed financial highlights for Q4 and full fiscal year 2024, operational and strategic updates, key ratios, revenue breakdown, capex details, and ESG focus. The content is structured as a presentation with slides and charts, typical of investor presentations. It is not a brief announcement or a certification letter, but a detailed presentation of financial results and company strategy. Therefore, the document fits the category of an Investor Presentation (IP).
2024-04-22 English
Dividend
Regulatory Filings
2024-04-22 English
Financial Result Updates
Regulatory Filings
2024-04-22 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 95% confidence The document is a notification to stock exchanges about an upcoming conference call to discuss the Q4 FY24 financial results of Epigral Limited. It references Regulation 30 and SEBI Listing Obligations, indicating a regulatory disclosure. The document does not contain any financial data or results itself, but rather announces the scheduling and details of the conference call where such results will be discussed. The length is short (2304 characters), and it is clearly an announcement rather than the transcript or report itself. Therefore, this fits the category of a Call Transcript announcement or notification. Since it is announcing the call, the best fitting category is Call Transcript (CT).
2024-04-17 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a certificate under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulation, 2018, for the quarter ended 31st March 2024. It is a confirmation certificate from the Registrar and Share Transfer Agent, submitted to stock exchanges. The document length is short (1256 characters) and it is a regulatory compliance certificate rather than a financial report or detailed filing. It does not contain financial statements or substantive financial data. Therefore, it fits the category of Regulatory Filings (RNS), which covers officer certifications and miscellaneous regulatory announcements that do not fit other categories.
2024-04-11 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.